Rationally Simplified Bistramide Analog Reversibly Targets Actin Polymerization and Inhibits Cancer Progression in Vitro and in Vivo
Authors:
- 10 May 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 132 (21) , 7288-7290
Abstract
We describe structure-based design and chemical synthesis of a simplified analog of bistramide A, which potently and reversibly binds monomeric actin with a Kd of 9.0 nM, depolymerizes filamentous actin in vitro and in A549 (nonsmall cell lung cancer) cells, inhibits growth of cancer cell lines in vitro at submicromolar concentrations, and significantly suppresses proliferation of A549 cells in a nude mice tumor xenograft model in terms of both tumor growth delay and average tumor volume. This study provides a conceptual framework for the design and development of new antiproliferative compounds that target cytoskeletal organization of cancer cells in vivo by a combination of reversible G-actin binding and effective F-actin severing.Keywords
This publication has 24 references indexed in Scilit:
- Antiproliferative Bistramides from Trididemnum cyclops from MadagascarJournal of Natural Products, 2009
- Actin-targeting natural products: structures, properties and mechanisms of actionCellular and Molecular Life Sciences, 2006
- Total synthesis and structure validation of (+)-bistramide CChemical Communications, 2005
- Synthesis of Bistramide AJournal of the American Chemical Society, 2004
- Small-Molecule Inhibitors of Actin Dynamics and Cell MotilityCurrent Topics in Medicinal Chemistry, 2003
- Total Synthesis of a Stereoisomer of Bistramide C and Assignment of Configuration of the Natural ProductChemistry – A European Journal, 2002
- New anti-actin drugs in the study of the organization and function of the actin cytoskeletonMicroscopy Research and Technique, 1999
- Bistramides A, B, C, D, and K: A New Class of Bioactive Cyclic Polyethers from Lissoclinum bistratumJournal of Natural Products, 1994
- Novel cytotoxic compounds from the ascidian Lissoclinum bistratumJournal of Medicinal Chemistry, 1989
- Proton Nuclear Magnetic Study of Bistramide A, a new cytotoxic drug isolated from Lissoclinum Bistratum SluiterTetrahedron, 1988